Bristol-Myers Squibb Rights
CELG.RT
21 hedge funds and large institutions have $189K invested in Bristol-Myers Squibb Rights in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
115% more capital invested
Capital invested by funds: $88K → $189K (+$101K)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
5% more funds holding
Funds holding: 20 → 21 (+1)
0.01% more ownership
Funds ownership: 0.02% → 0.03% (+0.01%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$48K |
| 2 |
MS
Maven Securities
St Helier,
Jersey
|
+$15.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$168 |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$8K |
| 2 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$3.35K |
| 3 |
CCM
Covington Capital Management
Los Angeles,
California
|
-$1K |
| 4 |
First Manhattan
New York
|
-$670 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $52K | +$48K | +215,051 | New |
|
|
MS
2
Maven Securities
St Helier,
Jersey
| $47K | +$15.1K | +67,856 | New |
|
|
TCA
3
Transcend Capital Advisors
Madison,
New Jersey
| $29K | – | – | – |
|
|
DC
4
Davenport & Co
Richmond,
Virginia
| $23K | – | – | – |
|
|
5L
5
55I LLC
Boston,
Massachusetts
| $21K | – | – | – |
|
6
Fifth Third Bancorp
Cincinnati,
Ohio
| $5K | – | – | – |
|
|
PWP
7
Private Wealth Partners
Mill Valley,
California
| $5K | – | – | – |
|
|
PAG
8
Private Advisor Group
Morristown,
New Jersey
| $4K | -$3.35K | -15,000 | -50% |
|
|
TPA
9
Trivium Point Advisory
Westport,
Connecticut
| $2K | – | – | – |
|
|
WQ
10
Wealth Quarterback
Toms River,
New Jersey
| $1K | +$240 | +1,076 | New |
|
|
VF
11
Virtu Financial
New York
| – | -$8K | -38,204 | Closed |
|
|
CCM
12
Covington Capital Management
Los Angeles,
California
| – | -$1K | -5,000 | Closed |
|
|
13
First Manhattan
New York
| – | -$670 | -3,000 | -75% |
|
|
14
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$1 | +6 | New |
|
|
15
UBS Group
Zurich,
Switzerland
| – | +$168 | +751 | +4,172% |
|
CELG.RT Hedge Fund Activity: Q2 2021 in Review
21 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q2 2021, worth a combined $189K — up 115% from $88K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CELG.RT positions and 3 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $48K. The largest seller was Virtu Financial, exiting entirely with an estimated $8K sold.
- 21 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q2 2021, up from 20 in Q1 2021.
- Funds reported $189K of Bristol-Myers Squibb Rights stock for Q2 2021, up 115% quarter-over-quarter.
- 4 funds opened new Bristol-Myers Squibb Rights positions in Q2 2021 and 3 closed out, a net change of +1 holder.
- The largest Bristol-Myers Squibb Rights buyer in Q2 2021 was Citadel Advisors, an estimated $48K added.
- The largest Bristol-Myers Squibb Rights seller in Q2 2021 was Virtu Financial, an estimated $8K sold.
Based on aggregated 13F filings for Q2 2021.